[go: up one dir, main page]

PL3331853T3 - Wybrany amid kwasu γ-hydroksymasłowego i jego zastosowania w leczeniu niewłaściwego użycia alkoholu - Google Patents

Wybrany amid kwasu γ-hydroksymasłowego i jego zastosowania w leczeniu niewłaściwego użycia alkoholu

Info

Publication number
PL3331853T3
PL3331853T3 PL16791313T PL16791313T PL3331853T3 PL 3331853 T3 PL3331853 T3 PL 3331853T3 PL 16791313 T PL16791313 T PL 16791313T PL 16791313 T PL16791313 T PL 16791313T PL 3331853 T3 PL3331853 T3 PL 3331853T3
Authority
PL
Poland
Prior art keywords
treatment
hydroxybutyric acid
alcohol misuse
selected amide
amide
Prior art date
Application number
PL16791313T
Other languages
English (en)
Inventor
Roberto Cacciaglia
Antonella Loche
Original Assignee
Laboratorio Farmaceutico C.T. S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Farmaceutico C.T. S.R.L. filed Critical Laboratorio Farmaceutico C.T. S.R.L.
Publication of PL3331853T3 publication Critical patent/PL3331853T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL16791313T 2015-08-04 2016-08-03 Wybrany amid kwasu γ-hydroksymasłowego i jego zastosowania w leczeniu niewłaściwego użycia alkoholu PL3331853T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITUB2015A002860A ITUB20152860A1 (it) 2015-08-04 2015-08-04 Selezionata amide dell?acido ?-idrossibutirrico e suoi usi nel trattamento dell?abuso da alcool
PCT/EP2016/068517 WO2017021438A1 (en) 2015-08-04 2016-08-03 SELECTED AMIDE OF γ -HYDROXYBUTYRIC ACID AND USES THEREOF IN THE TREATMENT OF ALCOHOL MISUSE
EP16791313.6A EP3331853B1 (en) 2015-08-04 2016-08-03 Selected amide of -hydroxybutyric acid and uses thereof in the treatment of alcohol misuse

Publications (1)

Publication Number Publication Date
PL3331853T3 true PL3331853T3 (pl) 2020-06-15

Family

ID=54542363

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16791313T PL3331853T3 (pl) 2015-08-04 2016-08-03 Wybrany amid kwasu γ-hydroksymasłowego i jego zastosowania w leczeniu niewłaściwego użycia alkoholu

Country Status (24)

Country Link
US (1) US10336687B2 (pl)
EP (1) EP3331853B1 (pl)
JP (1) JP6832336B2 (pl)
KR (1) KR102817897B1 (pl)
CN (1) CN108026029B (pl)
AU (1) AU2016302869B2 (pl)
CA (1) CA2994599C (pl)
CL (1) CL2018000282A1 (pl)
CO (1) CO2018002428A2 (pl)
DK (1) DK3331853T3 (pl)
EA (1) EA033769B9 (pl)
ES (1) ES2776628T3 (pl)
GE (1) GEP20207107B (pl)
IL (1) IL257314B (pl)
IT (1) ITUB20152860A1 (pl)
MX (1) MX2018001239A (pl)
MY (1) MY185942A (pl)
PH (1) PH12018550008A1 (pl)
PL (1) PL3331853T3 (pl)
PT (1) PT3331853T (pl)
SM (1) SMT202000337T1 (pl)
UA (1) UA121994C2 (pl)
WO (1) WO2017021438A1 (pl)
ZA (1) ZA201801402B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018310881C1 (en) 2017-07-31 2021-12-16 Novartis Ag Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use
JP2020529978A (ja) * 2017-07-31 2020-10-15 ノバルティス アーゲー アルコール使用の低減又はアルコール使用再燃の予防におけるマボグルラントの使用
CN113185403A (zh) * 2021-07-02 2021-07-30 山东国邦药业有限公司 一种甲醚制备环丙胺中间体环丙甲酸甲酯的方法
WO2023126076A1 (en) * 2022-01-03 2023-07-06 Laboratorio Farmaceutico C.T. S.R.L. Medical use of an amide of y-hydroxybutyric acid in the treatment of fragile x syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283782B1 (it) * 1996-08-09 1998-04-30 Ct Lab Farm Srl Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze,ed in particolare sell'alcolismo

Also Published As

Publication number Publication date
CN108026029B (zh) 2020-12-04
BR112018002245A2 (pt) 2018-09-18
IL257314B (en) 2020-04-30
EA033769B9 (ru) 2020-04-10
EA201890419A1 (ru) 2018-07-31
GEAP202014717A (en) 2020-01-27
AU2016302869B2 (en) 2020-10-22
AU2016302869A1 (en) 2018-03-15
ES2776628T3 (es) 2020-07-31
WO2017021438A1 (en) 2017-02-09
CL2018000282A1 (es) 2018-07-13
ZA201801402B (en) 2019-01-30
KR20180066033A (ko) 2018-06-18
JP6832336B2 (ja) 2021-02-24
US10336687B2 (en) 2019-07-02
EA033769B1 (ru) 2019-11-22
DK3331853T3 (da) 2020-03-16
US20180230086A1 (en) 2018-08-16
PH12018550008A1 (en) 2018-07-09
MX2018001239A (es) 2018-07-06
JP2018523644A (ja) 2018-08-23
SMT202000337T1 (it) 2020-07-08
MY185942A (en) 2021-06-14
CN108026029A (zh) 2018-05-11
UA121994C2 (uk) 2020-08-25
KR102817897B1 (ko) 2025-06-05
ITUB20152860A1 (it) 2017-02-04
IL257314A (en) 2018-03-29
GEP20207107B (en) 2020-05-11
EP3331853A1 (en) 2018-06-13
EP3331853B1 (en) 2019-12-11
CA2994599A1 (en) 2017-02-09
PT3331853T (pt) 2020-02-25
CA2994599C (en) 2023-08-29
CO2018002428A2 (es) 2018-07-10

Similar Documents

Publication Publication Date Title
IL290571A (en) Molecules that bind pd-1 and methods of using them
IL256179A (en) lag-3 binding molecules and methods of using them
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
SMT202000514T1 (it) Uso di acido cannabidiolico nel trattamento dell'epilessia
SG11201605383RA (en) Aflatoxin nanobody immunoabsorbent and immunoaffinity column and preparation method and use thereof
GB201513932D0 (en) Keratin treatment formulations and methods
IL265359A (en) Modified Oligonucleotides and Methods of Use
GB201511382D0 (en) Novel compounds and their use in therapy
ZA201704726B (en) Peptides and their use in the treatment of skin
SG11201608217PA (en) Fatty acid composition and use thereof
PL3277280T3 (pl) Izomiosmina do zastosowania w leczeniu chorób autoimmunologicznych
ZA201705400B (en) Compositions containing arsenic and their use in methods of treatment
ZA201801402B (en) SELECTED AMIDE OF γ -HYDROXYBUTYRIC ACID AND USES THEREOF IN THE TREATMENT OF ALCOHOL MISUSE
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
EP3110453A4 (en) Tmem100 peptides and variants thereof and their use in treating or preventing diseases or conditions
PL2862576T3 (pl) Drobnoustroje i zawierające je kompozycje do stosowania do leczenia lub profilaktyki zapalenia sutka
ZA201802201B (en) Novel formulation and treatment methods
PT3526244T (pt) Péptidos derivados do propéptido ntsr3 e a sua utilização no tratamento da depressão
AU2016905362A0 (en) Compounds and use thereof in methods of treatment
IL243402A0 (en) Methods for identifying preparations for use in the treatment of heart diseases and the use of preparations for the treatment of these diseases
GB201403086D0 (en) Selection of virus and agent useful in the treatment of cancer
ZA201408464B (en) Composition for the use in treatment of asthma